Therefore, we reveal that CuB can induce cellular mitophagy, inhibit glycolysis in pancreatic cancer cells, and improve the TME in terms of metabolic balance through the PI3K/Akt/mTOR and PINK1/Parkin pathways and LDHA downregulation. The gene discussed is PRKN; the disease is familial pancreatic carcinoma.